Search research articles
Contact Us
Filters
Showing results (81-90 of 113) with videos related to
Page
of 12
Sort By:
Bioorganic & Medicinal Chemistry Letters
|
October 20, 2009
Evaluation of substituted 6-arylquinazolin-4-amines as potent and selective inhibitors of cdc2-like kinases (Clk)
Bryan T Mott, Cordelle Tanega, Min Shen, et al.
Journal of Neuropathology and Experimental Neurology
|
May 17, 2005
Neuropathologic, biochemical, and molecular characterization of the frontotemporal dementias
Ryan T Mott, Dennis W Dickson, John Q Trojanowski, et al.
Blood Advances
|
February 9, 2021
Antileukemic efficacy of a potent artemisinin combined with sorafenib and venetoclax
Blake S Moses, Samantha McCullough, Jennifer M Fox, et al.
Journal of Neuro-Oncology
|
February 24, 2012
Patterns of failure after treatment of atypical meningioma with gamma knife radiosurgery
Albert Attia, Michael D Chan, Ryan T Mott, et al.
Oncotarget
|
January 16, 2016
Artemisinin-derived dimer ART-838 potently inhibited human acute leukemias, persisted in vivo, and synergized with antileukemic drugs
Jennifer M Fox, James R Moynihan, Bryan T Mott, et al.
Scientific Reports
|
November 25, 2016
mQC: A Heuristic Quality-Control Metric for High-Throughput Drug Combination Screening
Lu Chen, Kelli Wilson, Ian Goldlust, et al.
Oncogene
|
April 17, 2022
Targeting oncometabolism to maximize immunotherapy in malignant brain tumors
Joshua D Bernstock, Kyung-Don Kang, Neil V Klinger, et al.
Medchemcomm
|
December 4, 2012
A furoxan-amodiaquine hybrid as a potential therapeutic for three parasitic diseases()
Bryan T Mott, Ken Chih-Chien Cheng, Rajarshi Guha, et al.
Cancers
|
March 28, 2020
Inhibiting WNT Ligand Production for Improved Immune Recognition in the Ovarian Tumor Microenvironment
Whitney N Goldsberry, Selene Meza-Perez, Angelina I Londoño, et al.
Chemmedchem
|
February 8, 2014
A cell-permeable ester derivative of the JmjC histone demethylase inhibitor IOX1
Rachel Schiller, Giuseppe Scozzafava, Anthony Tumber, et al.
Page
of 12
Search research articles
Search
Showing results (81-90 of 113) with videos related to
Sort By:
Page
of 12
Bioorganic & Medicinal Chemistry Letters
|
October 20, 2009
Evaluation of substituted 6-arylquinazolin-4-amines as potent and selective inhibitors of cdc2-like kinases (Clk)
Bryan T Mott, Cordelle Tanega, Min Shen, et al.
Journal of Neuropathology and Experimental Neurology
|
May 17, 2005
Neuropathologic, biochemical, and molecular characterization of the frontotemporal dementias
Ryan T Mott, Dennis W Dickson, John Q Trojanowski, et al.
Blood Advances
|
February 9, 2021
Antileukemic efficacy of a potent artemisinin combined with sorafenib and venetoclax
Blake S Moses, Samantha McCullough, Jennifer M Fox, et al.
Journal of Neuro-Oncology
|
February 24, 2012
Patterns of failure after treatment of atypical meningioma with gamma knife radiosurgery
Albert Attia, Michael D Chan, Ryan T Mott, et al.
Oncotarget
|
January 16, 2016
Artemisinin-derived dimer ART-838 potently inhibited human acute leukemias, persisted in vivo, and synergized with antileukemic drugs
Jennifer M Fox, James R Moynihan, Bryan T Mott, et al.
Scientific Reports
|
November 25, 2016
mQC: A Heuristic Quality-Control Metric for High-Throughput Drug Combination Screening
Lu Chen, Kelli Wilson, Ian Goldlust, et al.
Oncogene
|
April 17, 2022
Targeting oncometabolism to maximize immunotherapy in malignant brain tumors
Joshua D Bernstock, Kyung-Don Kang, Neil V Klinger, et al.
Medchemcomm
|
December 4, 2012
A furoxan-amodiaquine hybrid as a potential therapeutic for three parasitic diseases()
Bryan T Mott, Ken Chih-Chien Cheng, Rajarshi Guha, et al.
Cancers
|
March 28, 2020
Inhibiting WNT Ligand Production for Improved Immune Recognition in the Ovarian Tumor Microenvironment
Whitney N Goldsberry, Selene Meza-Perez, Angelina I Londoño, et al.
Chemmedchem
|
February 8, 2014
A cell-permeable ester derivative of the JmjC histone demethylase inhibitor IOX1
Rachel Schiller, Giuseppe Scozzafava, Anthony Tumber, et al.
Page
of 12